Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLAT | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | KLHL18 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | CEBPE | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | TMCO6 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | NOD2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | RWDD2A | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | DNAJC25 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | CTSH | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | YKT6 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | BTNL2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |